AzTrials
AzTrials

StrokePhase 1NCT01104064

Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT

A Phase 1 study testing real rTMS combined with constraint induced therapy in people with Stroke, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The strategy in rehabilitating pediatric hemiplegia is to overcome "developmental disuse". Disruption of the excitability in the non-stroke hemisphere, with resultant increased excitability (disinhibition) in the stroke hemisphere, can be achieved with low-frequency repetitive transcranial magnetic stimulation (rTMS)… Read more about this study

Who is it for?
Ages 8 to 16 years
Conditions the study is for
Stroke
What is being tested?
real rTMS combined with constraint induced therapy
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
19 participants
Where
1 siteUnited States
Study dates
Feb 2010to Aug 2012
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • at least 10 degrees of active finger (metacarpophalangeal joint) and wrist flexion/extension motion,
  • ability to see whether a computer screen cursor is slightly above/below a target line,
  • ability to understand finger tracking test evidenced by a score above 0,
  • evidence of an MEP in paretic hand muscle with TMS testing of ipsilesional M1, age-equivalent receptive language function.

Who cannot join

  • metabolic disorders,
  • neoplasm,
  • seizures,
  • disorders of cellular migration and proliferation,
  • lack of age appropriate receptive language function,
  • expressive aphasia,
Show all 10Show fewer
  • pregnancy,
  • claustrophobia,
  • indwelling metal or MRI incompatible medical devices,
  • gross visual field cuts.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Minnesota

    Minneapolis, Minnesota, 55455

Other trials in United States

About this study

The strategy in rehabilitating pediatric hemiplegia is to overcome "developmental disuse". Disruption of the excitability in the non-stroke hemisphere, with resultant increased excitability (disinhibition) in the stroke hemisphere, can be achieved with low-frequency repetitive transcranial magnetic stimulation (rTMS), a noninvasive method of stimulating targeted areas of the brain. Furthermore, the disruptive effects of low-frequency rTMS can be increased and prolonged by preceding it with 6-Hz priming stimulation. We have recently demonstrated the safety of this priming/low-frequency rTMS in adults with stroke and we are currently engaged in an NIH-funded study exploring the effectiveness, mechanism and safety of serial treatments of rTMS combined with motor learning training. Very little research, however, has been attempted on interventions to promote brain reorganization and recovery in hemiplegia in children. Thus, this study will determine the effectiveness, mechanism, and safety of 5 treatments of 6-Hz primed low-frequency rTMS applied to the non-stroke hemisphere and combined with constraint induced therapy (CIT) to promote recovery of the paretic hand. Fifteen children with pediatric hemiplegia, age 8 -16 years, at each of two pediatric medical facilities (total N = 30), will be randomly assigned to one of two treatment groups that will receive treatment for 2 weeks. The rTMSreal/CIT group will receive alternating days of the real rTMS and CIT for 5 treatments of each. The rTMSsham/CIT group will receive alternating days of sham rTMS with real CIT for 5 treatments of each. Subjects will be tested at pretest and posttest. The hypotheses are: 1) the rTMS treatment will show no serious side effects, 2) both groups will show improvement in hand function but the rTMSsham/CIT group will show significantly greater improvement, 3) the rTMSreal/CIT group will also show significantly greater improvements in brain reorganization measured by paired-pulse TMS testing, cortical silent period testing, and fMRI. The proposed research is important because very little research on rehabilitation-induced brain reorganization has been done in pediatric hemiplegia. It is innovative because it applies a technique never used before, i.e. 6-Hz primed low-frequency rTMS combined with CIT. The potential impact of this research is a radical change to pediatric rehabilitation that accomplishes a higher functional recovery.

Read the detailed description
  1. Specific Aims The proposed research will explore a new method of promoting brain reorganization and recovery of function in children with hemiplegia. Evidence shows that although the brain has remarkable reorganization after neural insult, some changes are maladaptive and leave the individual with additional loss of function. In the adult, motor neurons in the ipsilesional (stroke) hemisphere that have survived the stroke can undergo a loss of excitability. Interhemispheric (transcallosal) inhibition is imposed on these neurons from the contralesional (non-stroke) hemisphere. In both the adult and the child, evidence suggests that increased ipsilateral projections from the contralesional hemisphere to the paretic hand, likely due to compensatory behaviors, actually compound the disability. We postulate that the effectiveness of paretic limb activity training can be enhanced when combined with electrophysiologic intervention that suppresses activity in the contralesional motor neurons. Repetitive transcranial magnetic stimulation (rTMS) is a potent and noninvasive way to influence the excitability of the brain. rTMS, at low frequencies, depresses neural function. By stimulating the contralesional motor cortex at low frequency, thereby depressing its interhemispheric inhibition of the ipsilesional motor cortex, a net excitatory effect (disinhibition) is induced upon the ipsilesional motor cortex. Preceding the low-frequency rTMS with priming rTMS (see below) has been shown to increase the magnitude of the after-effect. We have recently demonstrated the safety of single treatments of 6-Hz primed low-frequency rTMS in adults with stroke and we are currently engaged in an adult NIH R01-funded study exploring the effectiveness, mechanism and safety of serial treatments of rTMS combined with motor learning training. Failure to address the large gap in pediatric brain reorganization only perpetuates the use of conservative but likely suboptimal treatment strategies. Our long-term goal is to restore excitability to surviving but dormant motor neurons in the lesioned hemisphere of children with hemiplegia and thereby promote higher motor recovery. To achieve this goal, our objective is to combine the effects of 6-Hz primed low-frequency rTMS with a current form of motor learning training, constraint induced therapy (CIT), to achieve a synergism that may yield unprecedented brain reorganization and recovery of function.

Specific Aim #1: Examine the safety of five treatments of 6-Hz primed low-frequency rTMS alternating with five treatments of CIT in children with hemiplegia.

Adverse effects will be measured through observation for seizures, continual physician screening, evaluation of cognitive function and motor function in the nonparetic hand. The working hypothesis is:

  1. Five 6-Hz primed low-frequency rTMS treatments combined with CIT will not produce any seizure activity nor any other serious adverse effect.

Specific Aim #2. Determine the synergistic effect of rTMS combined with CIT on functional outcomes in children with hemiplegia.

Fifteen children with hemiplegia at each of two pediatric medical centers (total N=30) will be randomly assigned in equal numbers to one of two groups: rTMSreal/CIT, rTMSsham/CIT. The working hypotheses are:

  1. Both groups will show significant improvement in functional outcomes in the paretic hand at posttest compared to their pretest.
  2. The rTMSreal/CIT group will show significantly greater improvement in function in the paretic hand compared to the rTMSsham/CIT group.

Specific Aim #3: Explore the brain reorganization associated with 6-Hz primed low-frequency rTMS combined with CIT.

Treatment-induced brain reorganization in the ipsilesional hemisphere will be explored with evoked cortical excitability, using TMS for paired-pulse testing and cortical silent period testing, as well as with voluntary cortical recruitment using functional magnetic resonance imaging (fMRI). The working hypotheses are:

  1. Both groups will show significantly greater responses with TMS testing and fMRI testing at posttest compared to their pretest.
  2. The rTMSreal/CIT group will show significantly greater changes compared to the rTMSsham/CIT group.

This research is innovative in that it combines a unique form of noninvasive brain stimulation (primed low-frequency rTMS) with behavioral training (CIT) to promote a synergism that could achieve higher recovery in pediatric hemiplegia than through either treatment alone. The expected outcomes are improved hand function with no adverse effects leading to improved quality of life and reduced burden of care across the lifespan of children with hemiplegia.

Conditions
Stroke
Being tested
real rTMS combined with constraint induced therapy, sham rTMS combined with constraint induced therapy
Keywords
Stroke
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • real rTMS combined with constraint induced therapyDevice

    10 minutes of priming followed by 10 minutes of low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.

  • sham rTMS combined with constraint induced therapyDevice

    10 minutes of sham priming followed by 10 minutes of sham low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.

Study groups in NCT01104064
Study groupRoleWhat they receive
Real rTMS combined with CITExperimentalNot described
Receives: Device: real rTMS combined with constraint induced therapy
Sham rTMS combined with CITSham comparatorNot described
Receives: Device: sham rTMS combined with constraint induced therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hand function assessment

    Hand function will be assessed at pretest and posttest by a tester rating the child's performance on designated motor tasks

    Measured: Pretest, posttest

Secondary outcomes (1)
  1. cortical excitability

    Cortical excitability of the primary motor cortex of the stroke hemisphere will be assessed using paired-pulse transcranial magnetic stimulation.

    Measured: pretest and posttest

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2010 (estimated)
  2. Study startFeb 2010
  3. Primary completionAug 2012
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01104064
Sponsor's protocol ID
Pediatric Hemiplegia and rTMS
Status last verified
Aug 2013
First submitted
13 Apr 2010
Last updated
19 Aug 2013
Results posted
No
Data monitoring committee
No

Publications

  • Gillick BT, Krach LE, Feyma T, Rich TL, Moberg K, Menk J, Cassidy J, Kimberley T, Carey JR. Safety of primed repetitive transcranial magnetic stimulation and modified constraint-induced movement therapy in a randomized controlled trial in pediatric hemiparesis. Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S104-13. doi: 10.1016/j.apmr.2014.09.012. Epub 2014 Oct 2.

    PubMed 25283350
  • Gillick BT, Krach LE, Feyma T, Rich TL, Moberg K, Thomas W, Cassidy JM, Menk J, Carey JR. Primed low-frequency repetitive transcranial magnetic stimulation and constraint-induced movement therapy in pediatric hemiparesis: a randomized controlled trial. Dev Med Child Neurol. 2014 Jan;56(1):44-52. doi: 10.1111/dmcn.12243. Epub 2013 Aug 21.

    PubMed 23962321

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing real rTMS combined with constraint induced therapy in people with Stroke, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hand function assessment (time frame: Pretest, posttest). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01104064, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in